 | • レポートコード：QYR2104Z4010 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、ナノメディシンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ナノ粒子、ナノシェル、ナノチューブ、ナノデバイス、その他）、用途別市場規模（病院、診療所、研究機関）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ナノメディシンの市場動向 ・企業の競争状況、市場シェア ・ナノメディシンの種類別市場規模（ナノ粒子、ナノシェル、ナノチューブ、ナノデバイス、その他） ・ナノメディシンの用途別市場規模（病院、診療所、研究機関） ・ナノメディシンの北米市場規模2016-2027（アメリカ、カナダ） ・ナノメディシンのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ナノメディシンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ナノメディシンの中南米市場規模2016-2027（メキシコ、ブラジル） ・ナノメディシンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott、GE Healthcare、Johnson & Johnson、Merck、Pfizer、CombiMatrix、Celgene、Mallinckrodt、Sigma-Tau Pharmaceuticals、Teva Pharmaceutical、Nanosphere、UCB SA） ・結論 |
Nanotechnology refers to the engineering of functional systems at the molecular scale. It includes construction of items from the bottom up, using modern techniques and tools to make complete, high-performance products. Nanomedicines refer to medications that are based on the application of nanotechnology in the medical field. They include monitoring, construction, repair, and control of human biological systems at the molecular level, using nanodevices and nanostructures.
Factors such as aging populations, increasing prevalence of disorders that could be treated better with nanomedicines, and growing awareness about the availability of alternative treatment using nanomedicines are driving the global nanomedicines market.
Market Analysis and Insights: Global Nanomedicines Market
The global Nanomedicines market size is projected to reach US$ 232 million by 2026, from US$ 150 million in 2019, at a CAGR of 6.4% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nanomedicines market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nanomedicines market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nanomedicines market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nanomedicines market.
Global Nanomedicines Scope and Market Size
Nanomedicines market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Nanomedicines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Nanoparticles
Nanoshells
Nanotubes
Nanodevices
Others
Segment by Application
Hospitals
Clinics
Research Institute
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott
GE Healthcare
Johnson & Johnson
Merck
Pfizer
CombiMatrix
Celgene
Mallinckrodt
Sigma-Tau Pharmaceuticals
Merck
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nanomedicines Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Nanoparticles
1.2.3 Nanoshells
1.2.4 Nanotubes
1.2.5 Nanodevices
1.2.6 Others
1.3 Market by Application
1.3.1 Global Nanomedicines Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Institute
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Nanomedicines Market Perspective (2016-2027)
2.2 Nanomedicines Growth Trends by Regions
2.2.1 Nanomedicines Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Nanomedicines Historic Market Share by Regions (2016-2021)
2.2.3 Nanomedicines Forecasted Market Size by Regions (2022-2027)
2.3 Nanomedicines Industry Dynamic
2.3.1 Nanomedicines Market Trends
2.3.2 Nanomedicines Market Drivers
2.3.3 Nanomedicines Market Challenges
2.3.4 Nanomedicines Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nanomedicines Players by Revenue
3.1.1 Global Top Nanomedicines Players by Revenue (2016-2021)
3.1.2 Global Nanomedicines Revenue Market Share by Players (2016-2021)
3.2 Global Nanomedicines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Nanomedicines Revenue
3.4 Global Nanomedicines Market Concentration Ratio
3.4.1 Global Nanomedicines Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nanomedicines Revenue in 2020
3.5 Nanomedicines Key Players Head office and Area Served
3.6 Key Players Nanomedicines Product Solution and Service
3.7 Date of Enter into Nanomedicines Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nanomedicines Breakdown Data by Type
4.1 Global Nanomedicines Historic Market Size by Type (2016-2021)
4.2 Global Nanomedicines Forecasted Market Size by Type (2022-2027)
5 Nanomedicines Breakdown Data by Application
5.1 Global Nanomedicines Historic Market Size by Application (2016-2021)
5.2 Global Nanomedicines Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Nanomedicines Market Size (2016-2027)
6.2 North America Nanomedicines Market Size by Type
6.2.1 North America Nanomedicines Market Size by Type (2016-2021)
6.2.2 North America Nanomedicines Market Size by Type (2022-2027)
6.2.3 North America Nanomedicines Market Size by Type (2016-2027)
6.3 North America Nanomedicines Market Size by Application
6.3.1 North America Nanomedicines Market Size by Application (2016-2021)
6.3.2 North America Nanomedicines Market Size by Application (2022-2027)
6.3.3 North America Nanomedicines Market Size by Application (2016-2027)
6.4 North America Nanomedicines Market Size by Country
6.4.1 North America Nanomedicines Market Size by Country (2016-2021)
6.4.2 North America Nanomedicines Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Nanomedicines Market Size (2016-2027)
7.2 Europe Nanomedicines Market Size by Type
7.2.1 Europe Nanomedicines Market Size by Type (2016-2021)
7.2.2 Europe Nanomedicines Market Size by Type (2022-2027)
7.2.3 Europe Nanomedicines Market Size by Type (2016-2027)
7.3 Europe Nanomedicines Market Size by Application
7.3.1 Europe Nanomedicines Market Size by Application (2016-2021)
7.3.2 Europe Nanomedicines Market Size by Application (2022-2027)
7.3.3 Europe Nanomedicines Market Size by Application (2016-2027)
7.4 Europe Nanomedicines Market Size by Country
7.4.1 Europe Nanomedicines Market Size by Country (2016-2021)
7.4.2 Europe Nanomedicines Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Nanomedicines Market Size (2016-2027)
8.2 Asia-Pacific Nanomedicines Market Size by Type
8.2.1 Asia-Pacific Nanomedicines Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Nanomedicines Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Nanomedicines Market Size by Type (2016-2027)
8.3 Asia-Pacific Nanomedicines Market Size by Application
8.3.1 Asia-Pacific Nanomedicines Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Nanomedicines Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Nanomedicines Market Size by Application (2016-2027)
8.4 Asia-Pacific Nanomedicines Market Size by Region
8.4.1 Asia-Pacific Nanomedicines Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Nanomedicines Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Nanomedicines Market Size (2016-2027)
9.2 Latin America Nanomedicines Market Size by Type
9.2.1 Latin America Nanomedicines Market Size by Type (2016-2021)
9.2.2 Latin America Nanomedicines Market Size by Type (2022-2027)
9.2.3 Latin America Nanomedicines Market Size by Type (2016-2027)
9.3 Latin America Nanomedicines Market Size by Application
9.3.1 Latin America Nanomedicines Market Size by Application (2016-2021)
9.3.2 Latin America Nanomedicines Market Size by Application (2022-2027)
9.3.3 Latin America Nanomedicines Market Size by Application (2016-2027)
9.4 Latin America Nanomedicines Market Size by Country
9.4.1 Latin America Nanomedicines Market Size by Country (2016-2021)
9.4.2 Latin America Nanomedicines Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nanomedicines Market Size (2016-2027)
10.2 Middle East & Africa Nanomedicines Market Size by Type
10.2.1 Middle East & Africa Nanomedicines Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Nanomedicines Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Nanomedicines Market Size by Type (2016-2027)
10.3 Middle East & Africa Nanomedicines Market Size by Application
10.3.1 Middle East & Africa Nanomedicines Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Nanomedicines Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Nanomedicines Market Size by Application (2016-2027)
10.4 Middle East & Africa Nanomedicines Market Size by Country
10.4.1 Middle East & Africa Nanomedicines Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Nanomedicines Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Nanomedicines Introduction
11.1.4 Abbott Revenue in Nanomedicines Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 GE Healthcare
11.2.1 GE Healthcare Company Details
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Nanomedicines Introduction
11.2.4 GE Healthcare Revenue in Nanomedicines Business (2016-2021)
11.2.5 GE Healthcare Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Nanomedicines Introduction
11.3.4 Johnson & Johnson Revenue in Nanomedicines Business (2016-2021)
11.3.5 Johnson & Johnson Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Nanomedicines Introduction
11.4.4 Merck Revenue in Nanomedicines Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Nanomedicines Introduction
11.5.4 Pfizer Revenue in Nanomedicines Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 CombiMatrix
11.6.1 CombiMatrix Company Details
11.6.2 CombiMatrix Business Overview
11.6.3 CombiMatrix Nanomedicines Introduction
11.6.4 CombiMatrix Revenue in Nanomedicines Business (2016-2021)
11.6.5 CombiMatrix Recent Development
11.7 Celgene
11.7.1 Celgene Company Details
11.7.2 Celgene Business Overview
11.7.3 Celgene Nanomedicines Introduction
11.7.4 Celgene Revenue in Nanomedicines Business (2016-2021)
11.7.5 Celgene Recent Development
11.8 Mallinckrodt
11.8.1 Mallinckrodt Company Details
11.8.2 Mallinckrodt Business Overview
11.8.3 Mallinckrodt Nanomedicines Introduction
11.8.4 Mallinckrodt Revenue in Nanomedicines Business (2016-2021)
11.8.5 Mallinckrodt Recent Development
11.9 Sigma-Tau Pharmaceuticals
11.9.1 Sigma-Tau Pharmaceuticals Company Details
11.9.2 Sigma-Tau Pharmaceuticals Business Overview
11.9.3 Sigma-Tau Pharmaceuticals Nanomedicines Introduction
11.9.4 Sigma-Tau Pharmaceuticals Revenue in Nanomedicines Business (2016-2021)
11.9.5 Sigma-Tau Pharmaceuticals Recent Development
11.10 Teva Pharmaceutical
11.10.1 Teva Pharmaceutical Company Details
11.10.2 Teva Pharmaceutical Business Overview
11.10.3 Teva Pharmaceutical Nanomedicines Introduction
11.10.4 Teva Pharmaceutical Revenue in Nanomedicines Business (2016-2021)
11.10.5 Teva Pharmaceutical Recent Development
11.11 Nanosphere
11.11.1 Nanosphere Company Details
11.11.2 Nanosphere Business Overview
11.11.3 Nanosphere Nanomedicines Introduction
11.11.4 Nanosphere Revenue in Nanomedicines Business (2016-2021)
11.11.5 Nanosphere Recent Development
11.12 UCB SA
11.12.1 UCB SA Company Details
11.12.2 UCB SA Business Overview
11.12.3 UCB SA Nanomedicines Introduction
11.12.4 UCB SA Revenue in Nanomedicines Business (2016-2021)
11.12.5 UCB SA Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Nanomedicines Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Nanoparticles
Table 3. Key Players of Nanoshells
Table 4. Key Players of Nanotubes
Table 5. Key Players of Nanodevices
Table 6. Key Players of Others
Table 7. Global Nanomedicines Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Nanomedicines Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Nanomedicines Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Nanomedicines Market Share by Regions (2016-2021)
Table 11. Global Nanomedicines Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Nanomedicines Market Share by Regions (2022-2027)
Table 13. Nanomedicines Market Trends
Table 14. Nanomedicines Market Drivers
Table 15. Nanomedicines Market Challenges
Table 16. Nanomedicines Market Restraints
Table 17. Global Nanomedicines Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Nanomedicines Market Share by Players (2016-2021)
Table 19. Global Top Nanomedicines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanomedicines as of 2020)
Table 20. Ranking of Global Top Nanomedicines Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Nanomedicines Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Nanomedicines Product Solution and Service
Table 24. Date of Enter into Nanomedicines Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Nanomedicines Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Nanomedicines Revenue Market Share by Type (2016-2021)
Table 28. Global Nanomedicines Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Nanomedicines Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Nanomedicines Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Nanomedicines Revenue Market Share by Application (2016-2021)
Table 32. Global Nanomedicines Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Nanomedicines Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Nanomedicines Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Nanomedicines Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Nanomedicines Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Nanomedicines Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Nanomedicines Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Nanomedicines Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Nanomedicines Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Nanomedicines Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Nanomedicines Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Nanomedicines Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Nanomedicines Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Nanomedicines Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Nanomedicines Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Nanomedicines Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Nanomedicines Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Nanomedicines Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Nanomedicines Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Nanomedicines Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Nanomedicines Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Nanomedicines Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Nanomedicines Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Nanomedicines Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Nanomedicines Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Nanomedicines Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Nanomedicines Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Nanomedicines Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Nanomedicines Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Nanomedicines Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Nanomedicines Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Nanomedicines Market Size by Country (2022-2027) & (US$ Million)
Table 64. Abbott Company Details
Table 65. Abbott Business Overview
Table 66. Abbott Nanomedicines Product
Table 67. Abbott Revenue in Nanomedicines Business (2016-2021) & (US$ Million)
Table 68. Abbott Recent Development
Table 69. GE Healthcare Company Details
Table 70. GE Healthcare Business Overview
Table 71. GE Healthcare Nanomedicines Product
Table 72. GE Healthcare Revenue in Nanomedicines Business (2016-2021) & (US$ Million)
Table 73. GE Healthcare Recent Development
Table 74. Johnson & Johnson Company Details
Table 75. Johnson & Johnson Business Overview
Table 76. Johnson & Johnson Nanomedicines Product
Table 77. Johnson & Johnson Revenue in Nanomedicines Business (2016-2021) & (US$ Million)
Table 78. Johnson & Johnson Recent Development
Table 79. Merck Company Details
Table 80. Merck Business Overview
Table 81. Merck Nanomedicines Product
Table 82. Merck Revenue in Nanomedicines Business (2016-2021) & (US$ Million)
Table 83. Merck Recent Development
Table 84. Pfizer Company Details
Table 85. Pfizer Business Overview
Table 86. Pfizer Nanomedicines Product
Table 87. Pfizer Revenue in Nanomedicines Business (2016-2021) & (US$ Million)
Table 88. Pfizer Recent Development
Table 89. CombiMatrix Company Details
Table 90. CombiMatrix Business Overview
Table 91. CombiMatrix Nanomedicines Product
Table 92. CombiMatrix Revenue in Nanomedicines Business (2016-2021) & (US$ Million)
Table 93. CombiMatrix Recent Development
Table 94. Celgene Company Details
Table 95. Celgene Business Overview
Table 96. Celgene Nanomedicines Product
Table 97. Celgene Revenue in Nanomedicines Business (2016-2021) & (US$ Million)
Table 98. Celgene Recent Development
Table 99. Mallinckrodt Company Details
Table 100. Mallinckrodt Business Overview
Table 101. Mallinckrodt Revenue in Nanomedicines Business (2016-2021) & (US$ Million)
Table 102. Mallinckrodt Recent Development
Table 103. Sigma-Tau Pharmaceuticals Company Details
Table 104. Sigma-Tau Pharmaceuticals Business Overview
Table 105. Sigma-Tau Pharmaceuticals Nanomedicines Product
Table 106. Sigma-Tau Pharmaceuticals Revenue in Nanomedicines Business (2016-2021) & (US$ Million)
Table 107. Sigma-Tau Pharmaceuticals Recent Development
Table 108. Teva Pharmaceutical Company Details
Table 109. Teva Pharmaceutical Business Overview
Table 110. Teva Pharmaceutical Nanomedicines Product
Table 111. Teva Pharmaceutical Revenue in Nanomedicines Business (2016-2021) & (US$ Million)
Table 112. Teva Pharmaceutical Recent Development
Table 113. Nanosphere Company Details
Table 114. Nanosphere Business Overview
Table 115. Nanosphere Nanomedicines Product
Table 116. Nanosphere Revenue in Nanomedicines Business (2016-2021) & (US$ Million)
Table 117. Nanosphere Recent Development
Table 118. UCB SA Company Details
Table 119. UCB SA Business Overview
Table 120. UCB SA Nanomedicines Product
Table 121. UCB SA Revenue in Nanomedicines Business (2016-2021) & (US$ Million)
Table 122. UCB SA Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nanomedicines Market Share by Type: 2020 VS 2027
Figure 2. Nanoparticles Features
Figure 3. Nanoshells Features
Figure 4. Nanotubes Features
Figure 5. Nanodevices Features
Figure 6. Others Features
Figure 7. Global Nanomedicines Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Clinics Case Studies
Figure 10. Research Institute Case Studies
Figure 11. Nanomedicines Report Years Considered
Figure 12. Global Nanomedicines Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Nanomedicines Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Nanomedicines Market Share by Regions: 2020 VS 2027
Figure 15. Global Nanomedicines Market Share by Regions (2022-2027)
Figure 16. Global Nanomedicines Market Share by Players in 2020
Figure 17. Global Top Nanomedicines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanomedicines as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Nanomedicines Revenue in 2020
Figure 19. Global Nanomedicines Revenue Market Share by Type (2016-2021)
Figure 20. Global Nanomedicines Revenue Market Share by Type (2022-2027)
Figure 21. North America Nanomedicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Nanomedicines Market Share by Type (2016-2027)
Figure 23. North America Nanomedicines Market Share by Application (2016-2027)
Figure 24. North America Nanomedicines Market Share by Country (2016-2027)
Figure 25. United States Nanomedicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Nanomedicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Nanomedicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Nanomedicines Market Share by Type (2016-2027)
Figure 29. Europe Nanomedicines Market Share by Application (2016-2027)
Figure 30. Europe Nanomedicines Market Share by Country (2016-2027)
Figure 31. Germany Nanomedicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Nanomedicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Nanomedicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Nanomedicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Nanomedicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Nanomedicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Nanomedicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Nanomedicines Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Nanomedicines Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Nanomedicines Market Share by Region (2016-2027)
Figure 41. China Nanomedicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Nanomedicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Nanomedicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Nanomedicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Nanomedicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Nanomedicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Nanomedicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Nanomedicines Market Share by Type (2016-2027)
Figure 49. Latin America Nanomedicines Market Share by Application (2016-2027)
Figure 50. Latin America Nanomedicines Market Share by Country (2016-2027)
Figure 51. Mexico Nanomedicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Nanomedicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Nanomedicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Nanomedicines Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Nanomedicines Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Nanomedicines Market Share by Country (2016-2027)
Figure 57. Turkey Nanomedicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Nanomedicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Nanomedicines Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Abbott Revenue Growth Rate in Nanomedicines Business (2016-2021)
Figure 61. GE Healthcare Revenue Growth Rate in Nanomedicines Business (2016-2021)
Figure 62. Johnson & Johnson Revenue Growth Rate in Nanomedicines Business (2016-2021)
Figure 63. Merck Revenue Growth Rate in Nanomedicines Business (2016-2021)
Figure 64. Pfizer Revenue Growth Rate in Nanomedicines Business (2016-2021)
Figure 65. CombiMatrix Revenue Growth Rate in Nanomedicines Business (2016-2021)
Figure 66. Celgene Revenue Growth Rate in Nanomedicines Business (2016-2021)
Figure 67. Mallinckrodt Revenue Growth Rate in Nanomedicines Business (2016-2021)
Figure 68. Sigma-Tau Pharmaceuticals Revenue Growth Rate in Nanomedicines Business (2016-2021)
Figure 69. Teva Pharmaceutical Revenue Growth Rate in Nanomedicines Business (2016-2021)
Figure 70. Nanosphere Revenue Growth Rate in Nanomedicines Business (2016-2021)
Figure 71. UCB SA Revenue Growth Rate in Nanomedicines Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
世界のナノメディシン市場規模・現状・予測（2021年-2027年） Nanotechnology refers to the engineering of functional systems at the molecular scale. It includes construction of items from the bottom up, using modern techniques and tools to make complete, high-performance products. Nanomedicines refer to medications that are based on the application of nanotech…- 世界のナノ粒子市場規模・現状・予測（2021年-2027年） A nanoparticle is an individual molecule that behaves as a whole unit in terms of its transport and properties. The particle size of nanoparticles is 1 to 100 nanometers. The nanoparticles are further classified according to diameter as ultrafine particles (between 1 and 100 nanometers in size), fin…
- 世界のナノ粒子市場規模・現状・予測（2021年-2027年） A nanoparticle is an individual molecule that behaves as a whole unit in terms of its transport and properties. The particle size of nanoparticles is 1 to 100 nanometers. The nanoparticles are further classified according to diameter as ultrafine particles (between 1 and 100 nanometers in size), fin…
- 世界のナノメディシン市場規模・現状・予測（2021年-2027年） Nanomedicine is the medical application of nanotechnology.Nanomedicine ranges from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology such as biological machines. As per the WHO factsheet, …
- 世界の動物病院・獣医クリニックサービス市場規模・現状・予測（2021年-2027年） Veterinary Clinic are those premises at which veterinary surgery is practiced, but at which animals are not retained overnight. In veterinary hospitals veterinary surgery is practiced and animals receive treatment, nursing care, and other services. Services in veterinary hospitals include reception,…